Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 110
Filter
1.
Epidemiol Infect ; 147: e288, 2019 10 14.
Article in English | MEDLINE | ID: mdl-31607271

ABSTRACT

Viral pneumonia is an important cause of death and morbidity among infants worldwide. Transmission of non-influenza respiratory viruses in households can inform preventative interventions and has not been well-characterised in South Asia. From April 2011 to April 2012, household members of pregnant women enrolled in a randomised trial of influenza vaccine in rural Nepal were surveyed weekly for respiratory illness until 180 days after birth. Nasal swabs were tested by polymerase chain reaction for respiratory viruses in symptomatic individuals. A transmission event was defined as a secondary case of the same virus within 14 days of initial infection within a household. From 555 households, 825 initial viral illness episodes occurred, resulting in 79 transmission events. The overall incidence of transmission was 1.14 events per 100 person-weeks. Risk of transmission incidence was associated with an index case age 1-4 years (incidence rate ratio (IRR) 2.35; 95% confidence interval (CI) 1.40-3.96), coinfection as initial infection (IRR 1.94; 95% CI 1.05-3.61) and no electricity in household (IRR 2.70; 95% CI 1.41-5.00). Preventive interventions targeting preschool-age children in households in resource-limited settings may decrease the risk of transmission to vulnerable household members, such as young infants.


Subject(s)
Disease Transmission, Infectious , Family Characteristics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Viruses/isolation & purification , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Nasal Mucosa/virology , Nepal/epidemiology , Polymerase Chain Reaction , Randomized Controlled Trials as Topic , Rural Population , Viruses/classification , Young Adult
2.
Ann Clin Microbiol Antimicrob ; 15: 28, 2016 Apr 27.
Article in English | MEDLINE | ID: mdl-27121506

ABSTRACT

A state-wide pertussis outbreak occurred in Washington during the winter-spring months of 2012, concurrent with respiratory viral season. We compared performance characteristics of a laboratory-developed pertussis PCR (LD-PCR for Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii) and rapid multiplex PCR (RM-PCR) for respiratory viruses (FilmArray™, BioFire, B. pertussis data unblinded following FDA approval post outbreak). We analyzed three cohorts of patients using physician testing orders as a proxy for clinical suspicion for pertussis or respiratory viruses: Cohort 1, tested by LD-PCR for pertussis pathogens only by nasopharyngeal swab; Cohort 2, by RM-PCR for respiratory viruses only by mid-nasal turbinate swab; and Cohort 3, by both methods. B. pertussis was detected in a total of 25 of the 490 patients in Cohort 3 in which LD-PCR detected 20/25 (80 %) cases and the RM-PCR detected 24/25 (96 %; p = 0.2). Pertussis pathogens were detected in 21/584 (3.6 %) of samples from Cohort 1 where clinicians had a relatively strong suspicion for pertussis. In contrast, B. pertussis was detected in only 4/3071 (0.1 %) specimens from Cohort 2 where suspicion for pertussis was lower (p < 0.001 for comparison with Cohort 1). In summary, the two laboratory methods were comparable for the detection of B. pertussis.


Subject(s)
Bordetella parapertussis/isolation & purification , Bordetella pertussis/isolation & purification , Multiplex Polymerase Chain Reaction/methods , Polymerase Chain Reaction/methods , Whooping Cough/microbiology , Adolescent , Bordetella parapertussis/genetics , Bordetella pertussis/genetics , Child , Child, Preschool , Cohort Studies , DNA, Bacterial/genetics , Disease Outbreaks , Female , Humans , Infant , Male , Nasopharynx/microbiology , Retrospective Studies , United States/epidemiology , Whooping Cough/diagnosis , Whooping Cough/epidemiology
3.
Oncogene ; 35(14): 1832-46, 2016 Apr 07.
Article in English | MEDLINE | ID: mdl-26165838

ABSTRACT

Hepsin belongs to a family of cell-surface serine proteases, which have sparked interest as therapeutic targets because of the accessibility of extracellular protease domain for inhibitors. Hepsin is frequently amplified and/or overexpressed in epithelial cancers, but it is not clear how enhanced hepsin expression confers a potential for oncogenicity. We show that hepsin is consistently overexpressed in more than 40% of examined breast cancers, including all major biological subtypes. The effects of doxycycline-induced hepsin overexpression were examined in mammary epithelial organoids, and we found that induced hepsin acutely downmodulates its cognate inhibitor, hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1). Hepsin-induced depletion of cellular HAI-1 led to a sharp increase in pericellular serine protease activity. The derepressed hepsin proteolytically activated downstream serine proteases, augmented HGF/MET signalling and caused deterioration of desmosomes and hemidesmosomes; structures important for cell cohesion and cell-basement membrane interaction. Moreover, chronic induction of hepsin considerably shortened the latency of Myc-dependent tumourigenesis in the mouse mammary gland. The serine protease and uPA system inhibitor WX-UK1, identified as a micromolar range hepsin inhibitor, prevented hepsin from augmenting HGF/MET signalling and disrupting desmosomes and hemidesmosomes. The findings suggest that the oncogenic activity of hepsin arises not only from elevated expression level but also from depletion of HAI-1, events which together trigger gain-of-function activity impacting HGF/MET signalling and epithelial cohesion. Thus, hepsin overexpression is a major oncogenic conferrer to a serine protease activity involved in breast cancer dissemination.


Subject(s)
Breast Neoplasms/drug therapy , Hepatocyte Growth Factor/genetics , Proteinase Inhibitory Proteins, Secretory/genetics , Proto-Oncogene Proteins c-met/genetics , Serine Endopeptidases/biosynthesis , Animals , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Doxycycline/administration & dosage , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Mammary Glands, Animal , Mice , Proteinase Inhibitory Proteins, Secretory/biosynthesis , Serine Endopeptidases/genetics , Signal Transduction/drug effects , Xenograft Model Antitumor Assays
4.
Oncogene ; 35(11): 1386-98, 2016 Mar 17.
Article in English | MEDLINE | ID: mdl-26073086

ABSTRACT

Differentiated epithelial structure communicates with individual constituent epithelial cells to suppress their proliferation activity. However, the pathways linking epithelial structure to cessation of the cell proliferation machinery or to unscheduled proliferation in the context of tumorigenesis are not well defined. Here we demonstrate the strong impact of compromised epithelial integrity on normal and oncogenic Myc-driven proliferation in three-dimensional mammary epithelial organoid culture. Systematic silencing of 34 human homologs of Drosophila genes, with previously established functions in control of epithelial integrity, demonstrates a role for human genes of apico-basal polarity, Wnt and Hippo pathways and actin dynamics in regulation of the size, integrity and cell proliferation in organoids. Perturbation of these pathways leads to diverse functional interactions with Myc: manifested as a RhoA-dependent synthetic lethality and Par6-dependent effects on the cell cycle. Furthermore, we show a role for Par6G as a negative regulator of the phosphatidylinositol 3'-kinase/phosphoinositide-dependent protein kinase 1/Akt pathway and epithelial cell proliferation and evidence for frequent inactivation of Par6G gene in epithelial cancers. The findings demonstrate that determinants of epithelial structure regulate the cell proliferation activity via conserved and cancer-relevant regulatory circuitries, which are important for epithelial cell cycle restriction and may provide new targets for therapeutic intervention.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Carcinogenesis/genetics , Cell Proliferation/genetics , Epithelial Cells/metabolism , Neoplasms, Glandular and Epithelial/genetics , Apoptosis/genetics , Cell Line, Tumor , Epithelial Cells/cytology , Hippo Signaling Pathway , Humans , Mutation/genetics , Neoplasms, Glandular and Epithelial/pathology , Phosphatidylinositol 3-Kinase/metabolism , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-myc/genetics , RNA Interference , RNA, Small Interfering/genetics , Wnt Proteins/genetics , Wnt Signaling Pathway/genetics
5.
Anal Methods ; 8(14): 2880-2886, 2016 Apr 14.
Article in English | MEDLINE | ID: mdl-37457919

ABSTRACT

Sample preparation, including bacterial lysis, remains a hurdle in the realization of complete point-of-care tests for many pathogens. Here, we developed a sample preparation methodology for enzymatic lysis and sample heating for low-resource, point-of-care applications. We show an instrument-free chemical heater system for rapid lysis of a gram-positive bacterium (Staphylococcus aureus) and an RNA virus (human respiratory syncytial virus) using a dried lysis enzyme mixture (achromopeptidase) for S. aureus. After a lysis step (<1 minute), lysis enzymes are heat deactivated (<5 minutes) using a simple disposable chemical heater. We demonstrated that both DNA and RNA in the heat-treated sample could be directly amplified without purification, even in the presence of a clinically-obtained human nasal sample. This simple approach to dry enzyme storage and sample heating is adaptable to many applications where samples need to be lysed, including use in low-resource laboratories and in single-use or cartridge-based point-of-care diagnostic devices.

6.
Bone Marrow Transplant ; 49(9): 1205-11, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24978141

ABSTRACT

Parainfluenza virus type 3 (PIV-3) can cause severe respiratory illness among hematopoietic cell transplantation (HCT) recipients. Factors associated with PIV-3-specific Ab level, and the association between PIV-3 Ab levels and clinical outcomes in HCT recipients who acquire PIV-3 infection, are unknown. We evaluated PIV-3-specific hemagglutination inhibition Ab levels and clinical outcomes among 172 patients with PIV-3 infection following HCT. In a multivariable linear regression model, high post-transplantation Ab levels were independently associated with higher pre-transplantation recipient titer (mean difference 0.38 (95% confidence interval (CI), 0.26, 0.50), P<0.001). Significant associations between pre-HCT Ab titers in both patients and donors and occurrence of lower respiratory tract disease (LRD) after HCT were not observed. In conclusion, low pre-transplantation titers are associated with low Ab levels after HCT. The relationship between PIV-3 Ab levels and outcomes remain uncertain. Further study is needed to prospectively evaluate the dynamics of PIV-3-specific Ab responses and the relative contribution of PIV-3-specific Ab to protection from infection acquisition and progression to LRD.


Subject(s)
Antibodies, Viral/blood , Hematopoietic Stem Cell Transplantation/methods , Parainfluenza Virus 3, Human/immunology , Respirovirus Infections/immunology , Transplantation Conditioning/methods , Adult , Antibody Specificity , Female , Humans , Male , Middle Aged , Respirovirus Infections/blood , Retrospective Studies , Transplantation, Homologous , Treatment Outcome , Young Adult
7.
Transpl Infect Dis ; 14(6): 611-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23198963

ABSTRACT

BACKGROUND: Cytomegalovirus (CMV) infection may cause serious disease after hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT), but few reports describe ganciclovir (GCV) resistance in pediatric patients. OBJECTIVES: This study was performed to describe the clinical impact of CMV infection with UL97 mutation in pediatric transplant recipients. METHODS: Quantitative surveillance data for CMV infection in pediatric patients between October 2001 and February 2007 at the University of Washington were analyzed. Testing for UL97 mutation was performed in selected patients with prolonged CMV viremia despite therapy. Data associated with the detection of UL97 mutations were reviewed. RESULTS: CMV was detected in 89 pediatric transplant recipients. Among these, 39 had undergone HCT and 50 SOT (12 heart, 22 kidney, 15 liver, and 1 bilateral lung transplants). CMV with at least one UL97 sequence variation was detected in 5 patients: 4 HCT recipients (4/39, 10%) and 1 heart transplant recipient (1/50, 2%). All 5 pediatric patients were CMV seropositive before transplantation. Underlying conditions included chronic myelogenous leukemia, primary immunodeficiency disorders, and hypoplastic left heart syndrome. One known GCV drug-resistant mutation was detected in 2 HCT recipients (A594V). Three strain variants with mutations considered to have no significant impact on UL97 function (H469Y, N510S, and D605E) were detected. Two of these 5 patients died, 1 because of uncontrolled CMV infection and 1 with other complications. CONCLUSIONS: UL97 drug-resistant mutations occur in pediatric transplant recipients with CMV viremia and can cause serious disease. Screening for mutations conferring resistance to CMV antivirals should be considered for patients with persistent viremia during therapy and the sequences of UL97 mutations evaluated.


Subject(s)
Cytomegalovirus Infections/etiology , Cytomegalovirus/genetics , Ganciclovir/pharmacology , Heart Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/adverse effects , Phosphotransferases (Alcohol Group Acceptor)/genetics , Cytomegalovirus/drug effects , Cytomegalovirus Infections/virology , Gene Expression Regulation, Viral , Humans , Infant , Mutation , Retrospective Studies , Viral Load
8.
Transpl Infect Dis ; 12(6): 513-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21062390

ABSTRACT

Oseltamivir resistance in pandemic 2009 influenza A/H1N1 is caused by the neuraminidase mutation H275Y. This mutation has also been associated with in vitro resistance to peramivir, but few clinical cases have been described to date. Using allele-specific real-time reverse transcriptase polymerase chain reaction assay for the H275Y mutation, we were able to identify resistant H1N1 in a hematopoietic cell transplant recipient receiving intravenous peramivir therapy, and through serial testing we determined the molecular evolution of resistance. This case demonstrates that an H275Y mutant population can emerge early and replicate in vivo under peramivir antiviral pressure to become the major viral population.


Subject(s)
Cyclopentanes/therapeutic use , Drug Resistance, Viral/genetics , Guanidines/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Influenza A Virus, H1N1 Subtype/drug effects , Influenza, Human/drug therapy , Mutation , Neuraminidase/antagonists & inhibitors , Acids, Carbocyclic , Antiviral Agents/administration & dosage , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Cyclopentanes/administration & dosage , Cyclopentanes/pharmacology , Fatal Outcome , Guanidines/administration & dosage , Guanidines/pharmacology , Humans , Influenza A Virus, H1N1 Subtype/enzymology , Influenza A Virus, H1N1 Subtype/genetics , Influenza, Human/virology , Male , Middle Aged , Neuraminidase/genetics , Oseltamivir/pharmacology , Oseltamivir/therapeutic use
10.
Health Place ; 15(4): 1149-57, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19643655

ABSTRACT

The restorative potential of green outdoor environments for children in preschool settings was investigated by measuring the attention of children playing in settings with different environmental features. Eleven preschools with outdoor environments typical for the Stockholm area were assessed using the outdoor play environment categories (OPEC) and the fraction of visible sky from play structures (sky view factor), and 198 children, aged 4.5-6.5 years, were rated by the staff for inattentive, hyperactive and impulsive behaviors with the ECADDES tool. Children playing in large and integrated outdoor areas containing large areas of trees, shrubbery and a hilly terrain showed less often behaviors of inattention (p<.05). The choice of tool for assessment of attention is discussed in relation to outdoor stay and play characteristics in Swedish preschool settings. The results indicate that the restorative potential of green outdoor environments applies also to preschool children and that environmental assessment tools as OPEC can be useful when to locate and develop health-promoting land adjacent to preschools.


Subject(s)
Environment Design , Play and Playthings/psychology , Psychology, Child , Schools, Nursery , Attention , Child , Child, Preschool , Female , Humans , Male
11.
Pediatr Neurosurg ; 45(4): 276-80, 2009.
Article in English | MEDLINE | ID: mdl-19609096

ABSTRACT

OBJECTIVE: This paper reviews the frequency of central nervous system infections due to Haemophilus influenzae and Streptococcus pneumoniae associated with cerebrospinal fluid (CSF) shunts in pediatric patients. The need for immunizations in this patient population is also evaluated. PATIENTS: All patients with cerebrospinal fluid shunts except those with brain tumors seen in our clinics. METHODS: We reviewed data in three computer databases, kept prospectively recording details of CSF shunt procedures and CSF shunt-related infections. RESULTS: 1,226 patients underwent 3,889 shunt placements between 1957 and 2007. Twelve patients had 14 episodes of Haemophilus or pneumococcal infections. CONCLUSIONS: Children with CSF shunts are at high risk for infection with H. influenzae and S. pneumoniae. Routine immunizations during infancy in addition to the 23-valent polysaccharide pneumococcal vaccine should be highly and actively encouraged by health care providers caring for children with CSF shunts. Additional expanded-coverage vaccines should be utilized if and when they become available.


Subject(s)
Cerebrospinal Fluid Shunts/adverse effects , Haemophilus Infections/etiology , Haemophilus influenzae , Pneumococcal Infections/etiology , Streptococcus pneumoniae , Adolescent , Child , Child, Preschool , Follow-Up Studies , Haemophilus Infections/prevention & control , Humans , Infant , Pneumococcal Infections/prevention & control , Prospective Studies , Retrospective Studies , Young Adult
13.
J Comp Pathol ; 137 Suppl 1: S16-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17553516

ABSTRACT

The vaccination of human mothers during pregnancy leads to transplacental transfer of antibody which can provide protection to the neonate during early life. This active transfer is a receptor-mediated event with preferential transport of antibody of the IgG1 and IgG3 subclasses via the FcR(n) receptor. The efficiency of trans-placental transfer is dependent on a range of factors including: placental integrity, the total IgG concentration in maternal blood, the type of vaccine, the timing of vaccine administration during gestation, the gestational age of the fetus at birth and the IgG subclass involved. The kinetics of maternal and infant serological responses has been extensively studied using Haemophilus influenzae b (Hib) vaccination as a model.


Subject(s)
Antibody Formation/immunology , Immunity, Maternally-Acquired/immunology , Infant, Newborn/immunology , Bacterial Capsules , Female , Haemophilus Vaccines/immunology , Humans , Immunoglobulin G/immunology , Polysaccharides, Bacterial/immunology , Pregnancy , Time Factors , Vaccination
14.
J Agric Saf Health ; 11(1): 7-17, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15782885

ABSTRACT

There have been very few epidemiological studies dealing with pig farmers' musculoskeletal health. The aim of this study was to carry out a cross-section postal questionnaire survey dealing with musculoskeletal symptoms among female and male pig farmers in large-scale production. The participation rate overall was 70% (288/410). Over 10% of the questionnaires had missing gender data. Three different questionnaires were used: the general standardized Nordic questionnaire for the analysis of musculoskeletal symptoms; a questionnaire dealing with occurrence of numbness, reduced muscle strength, etc., in the wrists and hands; and occupational factors were screened by a special questionnaire. The results showed that musculoskeletal morbidity is high among pig farmers. The women had significantly more problems than the men with respect to the upper extremities. Symptoms in the wrists and hands such as numbness, reduced muscle strength, aching fingers and wrists, and tendency to drop things were significantly more common among the women than the men. Occupational factors dealing with, for example, the size of the pig farm, were not related to the occurrence of symptoms. Occupational factors of importance for the development of disorders, particularly among women pig farmers, should be given priority in ergonomic interventions.


Subject(s)
Agricultural Workers' Diseases/epidemiology , Musculoskeletal Diseases/epidemiology , Adult , Aged , Agricultural Workers' Diseases/etiology , Animal Husbandry , Animals , Cross-Sectional Studies , Female , Gender Identity , Humans , Male , Middle Aged , Musculoskeletal Diseases/etiology , Prevalence , Risk Factors , Sex Factors , Surveys and Questionnaires , Sweden/epidemiology , Swine , Upper Extremity
15.
J Agric Saf Health ; 10(4): 247-56, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15603224

ABSTRACT

Pronator syndrome (median nerve entrapment at the elbow) is a rare condition, but it is more common among women than men. A long-term retrospective follow-up study evaluating the outcome of surgical release of the median nerve for female machine milkers has never been carried out before, nor has a long-term study of non-treated female milkers with pronator syndrome. In the present study, two groups of machine milkers (surgical and non-surgical) were compared. The clinical examination focused on two parameters: focal tenderness and individual muscle strength. The results showed that the surgical group had no focal tenderness on palpation over the median nerve at the elbow and no selective weakness in the muscles examined, as compared to what was found before surgery. In the non-surgical group, focal tenderness was found in 12 out of 14, and 10 out of 14 showed the same weakness as in an earlier examination. While this study has limitations in sample size, surgical release of the median nerve at the elbow level, in cases of pronator syndrome, appears to provide an immediate as well as long-term return to normal strength of FPL and FDP II, along with a significant improvement in subjective status. In the non-surgical group, spontaneous improvement of the strength of FPL and FDP II was found in only four out of the 14 cases.


Subject(s)
Agricultural Workers' Diseases/epidemiology , Dairying/instrumentation , Median Neuropathy/epidemiology , Nerve Compression Syndromes/epidemiology , Adult , Aged , Agricultural Workers' Diseases/etiology , Agricultural Workers' Diseases/prevention & control , Female , Forearm/innervation , Humans , Longitudinal Studies , Median Nerve , Median Neuropathy/etiology , Median Neuropathy/prevention & control , Middle Aged , Nerve Compression Syndromes/etiology , Nerve Compression Syndromes/prevention & control , Neurologic Examination , Pronation , Retrospective Studies , Surveys and Questionnaires , Sweden/epidemiology
16.
Vaccine ; 20(5-6): 826-37, 2001 Dec 12.
Article in English | MEDLINE | ID: mdl-11738746

ABSTRACT

In a randomized, double blinded study, 23-valent pneumococcal polysaccharide vaccine (PSV) or conjugate Haemophilus influenzae type b (HbOC) vaccine was administered to 60 healthy women in the third trimester of gestation. Total IgG, IgG1, and IgG2 antibodies to pneumococcal serotypes 6B, 14, 19F and 23F were measured by ELISA in mothers prior to immunization, at delivery and 7 months after delivery, and in infants at birth (cord blood), 2 and 7 months after delivery. IgA was evaluated in breast milk at 2 and 7 months, and opsonophagocytic activity in cord blood. PSV was safe and immunogenic in pregnant women. Transplacental transmission of vaccine-specific antibodies was efficient. Maternal immunization with PSV resulted in significantly higher concentrations of pneumococcal antibodies in infants at birth and at 2 months of age, and greater functional opsonophagocytic activity of passively acquired IgG antibody.


Subject(s)
Immunity, Maternally-Acquired , Pneumococcal Vaccines/administration & dosage , Adult , Antibodies, Bacterial/blood , Carrier State/immunology , Carrier State/microbiology , Carrier State/prevention & control , Double-Blind Method , Female , Humans , Immunoglobulin G/blood , Infant , Infant, Newborn , Milk, Human/immunology , Nasal Mucosa/microbiology , Opsonin Proteins/blood , Phagocytosis , Pneumococcal Infections/immunology , Pneumococcal Infections/microbiology , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines/adverse effects , Pregnancy , Pregnancy Trimester, Third , Prospective Studies , Safety , Streptococcus pneumoniae/immunology , Streptococcus pneumoniae/isolation & purification
18.
Pediatr Infect Dis J ; 20(10): 931-40, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11642626

ABSTRACT

BACKGROUND: Immunization of healthy women before pregnancy is a potential approach to providing increased levels of maternal antibody to newborns to protect them from infections occurring during the perinatal period and first months of life. METHODS: Healthy nonpregnant Pima Indian women of childbearing age were randomized to receive one of two Haemophilus influenzae type b (Hib) conjugate vaccines [HbOC or Hib-meningococcal outer membrane protein complex (OMP)] or a 23-valent pneumococcal polysaccharide vaccine (PnPs). Infants received Hib-OMP vaccine at 2, 4 and 12 months of age. Vaccine safety and immunogenicity was evaluated in the women and their infants. RESULTS: Anti-polyribose ribitol phosphate antibody titers were significantly higher in women in both Hib conjugate vaccine groups than in the pneumococcal vaccine group throughout the 37-month observation period. Antibody responses to HbOC vaccine were significantly higher than those to Hib-OMP. A subsequent booster dose of each Hib conjugate vaccine induced reactions and antibody responses similar to those of the first dose. Infants born to mothers immunized with Hib vaccines compared with PnPs had significantly higher polyribose ribitol phosphate-specific IgG antibody titers at birth and 2 months of age but lower antibody responses to Hib-OMP at 6 months and similar titers before and after boosting with Hib-OMP at 1 year of age. By contrast women immunized with PnPs did not have significantly elevated concentrations of pneumococcal-specific antibody at delivery, and their infants had pneumococcal antibody titers similar to those of infants born to mothers who did not receive pneumococcal vaccine before pregnancy. CONCLUSION: Hib conjugate vaccine given to women before pregnancy significantly increased the proportion of infants who had protective Hib antibody levels at birth and 2 months of age.


Subject(s)
Haemophilus Infections/immunology , Haemophilus Infections/prevention & control , Haemophilus Vaccines/therapeutic use , Haemophilus influenzae type b/immunology , Pneumococcal Vaccines/therapeutic use , Polysaccharides, Bacterial/therapeutic use , Adolescent , Adult , Antibodies, Bacterial/blood , Bacterial Capsules , Enzyme-Linked Immunosorbent Assay , Female , Fetal Blood , Haemophilus Vaccines/adverse effects , Humans , Immunoglobulin G/blood , Infant , Infant, Newborn , Pneumococcal Vaccines/adverse effects , Polysaccharides, Bacterial/adverse effects , Preconception Care , Pregnancy , Treatment Outcome , Vaccines, Conjugate/therapeutic use
19.
Can J Microbiol ; 47(4): 302-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11358169

ABSTRACT

Sole carbon source utilization (SCSU) patterns and phospholipid fatty acid (PLFA) profiles were compared with respect to their potential to characterize root-inhabiting microbial communities of hydroponically grown crops. Sweet pepper (Capsicum annum cv. Evident), lettuce (Lactuca sativa cv. Grand Rapids), and four different cultivars of tomato (Lycopersicon esculentum cvs. Gitana, Armada, Aromata, and Elin) were grown in 1-L black plastic beakers placed in a cultivation chamber with artificial light. In addition to the harvest of the plants after 6 weeks, plants of one tomato cultivar, cv. Gitana, were also harvested after 4 and 8 weeks. The cultivation in this study was performed twice. Principal component analysis was used to analyze the data. Both characterization methods had the ability to discriminate between the root microflora of different plant species, cultivars, and one tomato cultivar at different ages. Differences in both SCSU patterns and PLFA profiles were larger between plant species than between cultivars, but for both methods the largest differences were between the two cultivations. Still, the differences between treatments were always due to differences in the same PLFAs in both cultivations. This was not the case for the SCSU patterns when different plant ages were studied. Furthermore, PLFA profiles showed less variation between replicates than did SCSU patterns. This larger variation observed among the SCSU data indicates that PLFA may be more useful to detect changes in the root microflora of hydroponically grown crops than the SCSU technique.


Subject(s)
Carbon/metabolism , Crops, Agricultural/microbiology , Fatty Acids/biosynthesis , Hydroponics , Phospholipids/metabolism , Plant Roots/microbiology , Capsicum/microbiology , Crops, Agricultural/metabolism , Fatty Acids/analysis , Lactuca/microbiology , Solanum lycopersicum/microbiology , Multivariate Analysis , Plant Roots/metabolism , Plants, Medicinal
20.
Infect Dis Clin North Am ; 15(1): 253-71, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11301819

ABSTRACT

The concept of maternal immunization to prevent infectious diseases during a period of increased vulnerability in the infant is supported by historical experience and carefully conducted studies of various viral and bacterial vaccines. Candidate vaccines should be minimally reactogenic, immunogenic, and safe. Health education and access to immunization should be a priority if maternal immunization is to succeed as a disease prevention strategy. The potential effect on the incidence of disease in the newborn and young infant can only increase as more candidate vaccines that could be administered during pregnancy become available. In the future, common infections and other, more dreaded diseases, such as herpes simplex virus infection, cytomegalovirus, and human immunodeficiency virus infection, could be prevented with this intervention. Further research on the safety and efficacy of maternal immunization must continue if the occurrence of serious infectious diseases in neonates and young infants is to be reduced.


Subject(s)
Immunity, Maternally-Acquired , Adult , Bacterial Vaccines/administration & dosage , Female , Guidelines as Topic , Humans , Immunization, Passive , Infant, Newborn , Influenza Vaccines/administration & dosage , Pregnancy , Safety , Tetanus Toxoid/administration & dosage , Vaccination , Vaccines, Combined/administration & dosage , Viral Vaccines/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...